Acinetobacter baumannii Secretes a Bioactive Lipid That Triggers Inflammatory Signaling and Cell Death
is a highly pathogenic Gram-negative bacterium that causes severe infections with very high fatality rates. infection triggers innate as well as adaptive immunity, however, our understanding of the inflammatory factors secreted by that alarm the immune system remains limited. In this study, we repor...
Saved in:
Published in | Frontiers in microbiology Vol. 13; p. 870101 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
09.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | is a highly pathogenic Gram-negative bacterium that causes severe infections with very high fatality rates.
infection triggers innate as well as adaptive immunity, however, our understanding of the inflammatory factors secreted by
that alarm the immune system remains limited. In this study, we report that the lab adapted and clinical strains of
secrete an inflammatory bioactive factor which activates TLR2, leading to canonical IRAK4-dependent NF-κB signaling and production of pro-inflammatory cytokines interleukin (IL)-6 and IL-8 and activation of the inflammasome pathway causing pyroptotic cell death. Biochemical fractionation of the
culture filtrate revealed the hydrophobic nature of the inflammatory factor. Concordantly, lipase treatment of the culture filtrate or TLR2 inhibition in macrophages abrogated NF-κB activation and cell death induction. Culture filtrates from the LPS- and lipoprotein-deficient
mutants retain immuno-stimulatory properties suggesting that a lipid other than these known stimulatory molecules can trigger inflammation during
infection. Our results reveal that
secretes a previously unappreciated inflammatory bioactive lipid that activates multiple pro-inflammatory signaling pathways and induces cell death in human and murine macrophages. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Daniel Pletzer, University of Otago, New Zealand Present address: Varnesh Tiku, Vir Biotechnology, San Francisco, CA, United States Reviewed by: Bernahrd Ryffel, Centre National de la Recherche Scientifique (CNRS), France; Attinder Chadha, Independent Researcher, Delhi, India; Farzam Vaziri, University of California, Davis, United States These authors have contributed equally to this work This article was submitted to Infectious Agents and Disease, a section of the journal Frontiers in Microbiology |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2022.870101 |